Syngenta CEO sees dual listing for company in Europe, US


Syngenta AG, the Swiss pesticide maker acquired by China National Chemical Corp for US$43 billion, is considering bourses in Europe and the US as possible locations for a re-listing of shares in about five years.

"I would not be surprised if it was a combination of Europe and the US, as we were before," Syngenta chief executive officer Erik Fyrwald said in an interview in Brussels Monday, adding that the final decision would depend on a number of factors at the time of listing.

ChemChina's Ren Jianxin, now Syngenta chairman, has said he plans a minority listing of the Basel, Switzerland-based company within a period of about five years.

With ChemChina's 18-month acquisition process almost complete, Syngenta is seeking to get a head start on rivals Dow Chemical Co and DuPont Co, as well as Monsanto Co and Bayer AG, which are still tied up with their respective mergers.

Syngenta is looking to strengthen its position as No 3 in seeds and would examine all divestments made by its competitors to comply with antitrust regulators, Mr Fyrwald said.
SEE ALSO: Fed rate hikes of little concern: economists

Syngenta and BASF SE have submitted preliminary bids for the Bayer assets, people familiar with the matter have said. The disposals, which include canola, cottonseeds, the LibertyLink herbicide-resistant trait and the glufosinate weed killer, may fetch between US$2.5 billion and US$3 billion, the people have said.

While Mr Fyrwald declined to say how much he thinks the assets are worth, he said Syngenta is prepared to spend a "significant" amount on acquisitions.

"We are very interested in acquiring additional seed assets and we'll be taking a look at all the remedy assets and others as they become available," the CEO said.

Readers choice: TOP-5 articles of the month by UkrAgroConsult